estimation – Page 2 – Communicable Diseases Research

In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology

역백신학을 이용한 오미크론 균주에 대한 In silico SARS-CoV-2 백신 개발

Article

Published on 2022-08-012022-09-11
Journal: Genes & genomics [Category] COVID19(2023년), SARS, 변종,

[키워드] 3D structure 3D Structures ACE2 ACE2 receptor acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 allergenicity angiotensin angiotensin converting enzyme angiotensin converting enzyme 2 antigenic antigenicity applied B cell epitope B cell epitopes B.1.1.529 binding collected coronavirus develop Efficacy effort enzyme epitope Epitopes estimation final vaccine construct Health Organization in silico MHC I MHC II molecular docking analysis Mutation non-allergenic non-toxic omicron pandemic Physicochemical properties physicochemical property predict predicted Prevent profile RaptorX reduce reverse vaccinology SARS-CoV-2 SARS-CoV-2 vaccine second secondary structure secondary structures selected severe acute respiratory syndrome Coronavirus solubility Spread stability Structure tested the vaccine Toxicity Vaccine vaccine candidate vaccine construct Vaccine design Vaccines variant viral genome sequences virus VoC was performed were used WHO wild type World Health Organization
[DOI] 10.1007/s13258-022-01255-8 PMC 바로가기 [Article Type] Article

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study

종적 SARS-CoV-2 바이러스 부하 데이터에서 감염 시기 추정: 수학적 모델링 연구

Article

Published on 2022-07-282022-09-11
Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종,

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection

병원 내 SARS-CoV-2 델타 변이형 돌발성 감염에 대한 백신 접종 후 항체 평가

Observational Study

Published on 2022-07-252022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 anti-S IgG Anti-spike anti-spike antibody antibody Asymptomatic B.1.617.2 BNT162b2 booster vaccination Breakthrough infection Care Casirivimab characterized collected coronavirus Course Delta variants diagnosed Diagnosis eight estimation geometric mean geometric mean titer GMT hospital Humoral immunity IgG Imdevimab Infection Inpatient LAMP Loop-mediated isothermal amplification lowest measurement Mild mild to moderate mild to moderate severity moderate monoclonal antibody mRNA vaccination nosocomial observational study outbreak public health quantified RBD protein remained respiratory retrospective risk RT-PCR SARS-CoV-2 SARS-CoV-2 delta SARS-COV-2 infection SARS-CoV-2 vaccination Sequencing serological serum sample serum samples Seven severe acute respiratory syndrome Coronavirus severity therapy Treatment uninfected vaccination variant virus viruses was done whole-genome sequencing
[DOI] 10.1371/journal.pone.0272056 PMC 바로가기 [Article Type] Observational Study

Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated

위약군 백신 접종 후 나타나는 변이체에 대한 백신 효능 추정

Article

Published on 2022-07-202022-09-11
Journal: Statistics in medicine [Category] COVID19(2023년), SARS, 변종, 임상,

InjectMeAI-Software Module of an Autonomous Injection Humanoid

InjectMeAI-자율주입 휴머노이드의 소프트웨어 모듈

Article

Published on 2022-07-152022-09-11
Journal: Sensors (Basel, Switzerland) [Category] COVID19(2023년), SARS, 변종, 치료기술,

Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination

감염 및 백신 접종 후 SARS-CoV-2 항체 결합력 반응의 역학

Article

Published on 2022-07-082022-09-11
Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Algorithm antibody Antibody avidity antibody levels Antibody Response Antibody responses avidity Cohort coronavirus COVID-19 pandemic Critical domain Epidemics estimation FIVE healthcare worker Healthcare workers IgA IgA antibodies IgA antibody IgG Including Inclusion Infection information kinetic Kinetics multiplex Multiplex assay nucleocapsid nursing home performed RBD respiratory response SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-COV-2 infection Serological assay serological assays serology severe acute respiratory syndrome Coronavirus spike subunit the SARS-CoV-2 time since infection vaccination waned while
[DOI] 10.3390/v14071491 PMC 바로가기 [Article Type] Article

RWD2 Variation in COVID-19 Treatment Cost due to Social Factors in the US – Estimation Using Integration of CDC/ATSDR’s Social Vulnerability Index (SVI) and Healthcare Claims Data

Conference abstract

Published on 2022-07-012022-10-05
Journal: Value in health : the journal of the International [Category] 치료법,

[키워드] COVID-19 estimation Factor index integration vulnerability
[DOI] 10.1016/j.jval.2022.04.1526 [Article Type] Conference abstract

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022

전자 건강 등록을 사용하는 65세 이상 개인의 입원에 대한 COVID-19 백신 효과의 추정; 4개 EU/EEA 국가에서 2021년 10월부터 2022년 3월까지 파일럿 연구

Article

Published on 2022-07-012022-09-11
Journal: Eurosurveillance [Category] Coronavirus, Fulltext, MERS, 변종,

Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection

바이오마커로서의 Lp-PLA2 및 SARS-CoV-2 감염과의 가능한 연관성

Review

Published on 2022-07-012022-09-11
Journal: Biomarkers in Medicine [Category] COVID19(2023년), MERS, SARS, 바이오마커,

Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies

역학 연구를 위한 건조혈점 기반 COVID-19 혈청학적 분석의 개발 및 구현

Article

Published on 2022-06-292022-09-11
Journal: Microbiology Spectrum [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] addition alternative ambient ambient temperatures antibodies antibody antibody kinetics antibody levels Antibody Response Antibody responses Bay Blood changes in Cohort Community comparable COVID-19 COVID-19 pandemic Critical DBS sample DBS samples detect development dried blood spot Dried blood spots East Effectiveness enzyme enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays estimate estimation Immunity implementation inaccessible Infection Infectious disease Infectious diseases invasive Measures pandemic participant pathogen pathogen-specific phlebotomy Postinfection Prevalence Prevent public health measures Public health responses refrigeration risk factor Risk factors San Francisco SARS-CoV-2 SARS-COV-2 infection serological serological assays serological data serological studies serological surveillance serological survey serology Seroprevalence specific antibodies Spread stability storage study participant Study participants study population Surveillance Traditional vaccination venipuncture venous venous blood
[DOI] 10.1128/spectrum.02471-21 PMC 바로가기 [Article Type] Article